Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Provir effective in acute diarrhea

Nov. 15, 1996

Therapeutic effect of Lilly antioxidant demonstrated in rat model of IBD

Nov. 15, 1996

Roberts to license Lilly gastrointestinal compounds

Nov. 15, 1996

New 5-HT3/5-HT4 antagonists from Synthelabo

Nov. 15, 1996

Anti-H. pylori agents disclosed by Shiseido

Nov. 15, 1996

Natural anti-H. pylori compounds described by Terumo

Nov. 15, 1996

Approval recommended for primary biliary cirrhosis Rx

Nov. 8, 1996

Patent coverage for new HBV treatment licensed to Vion

Nov. 8, 1996

Rabeprazole + amoxicillin for eradication of H. pylori

Nov. 8, 1996

Anti-H. pylori antisense oligonucleotides reported by SCRAS

Nov. 8, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...